Africa bears world’s highest death rates from drug-resistant infections- WHO

In a message to mark World Antimicrobial Resistance Awareness Week 2026, observed from November 18 to 24, Janabi said the discovery of antibiotics, particularly penicillin, transformed medicine by making previously fatal infections treatable and improving the safety of surgery, cancer treatment and organ transplantation.
However, he warned that antimicrobial resistance threatens these gains, as bacteria, viruses, fungi and parasites increasingly develop resistance to medicines designed to eliminate them.
According to WHO, bacterial antimicrobial resistance was associated with an estimated 4.7 million deaths globally in 2021, while sub-Saharan Africa recorded the highest rates of AMR-associated mortality, compounding pressure on healthcare systems and households.
This year’s World AMR Awareness Week is themed “One Health, One Action: Prevent AMR now,” highlighting the interconnectedness of human, animal, plant and environmental health and the need for coordinated action across these sectors to slow the spread of drug resistance.
Janabi said inappropriate use of antimicrobials in humans and animals accelerates resistance, while poor infection prevention, inadequate water and sanitation, and unsafe waste disposal contribute to the spread of resistant organisms.
He said preventing infections, improving hygiene, expanding vaccination, ensuring access to clean water and strengthening infection prevention in health facilities and farms must form the foundation of efforts to combat AMR.
Despite the growing threat, Janabi noted that countries across the WHO African Region have made progress in developing frameworks to tackle resistance. He said all 47 member states have national action plans on AMR and are enrolled in WHO’s Global Antimicrobial Resistance and Use Surveillance System, although implementation of the plans varies across countries.
He added that 44 countries can now perform susceptibility testing for priority bacterial pathogens, enabling health professionals to determine which antibiotics are likely to work against specific infections and improve treatment decisions, while 36 countries have also adopted WHO’s Access, Watch and Reserve (AWaRe) classification of antibiotics, which guides appropriate prescribing and helps limit the misuse of medicines that are critical for treating serious infections.
The framework supports a global target of ensuring that at least 70 percent of antibiotics used in human health come from the Access group by 2030, a category of antibiotics considered appropriate for treating common infections and with lower resistance potential than other groups.
Janabi commended governments and regional partners, including the Food and Agriculture Organisation of the United Nations, the United Nations Environment Programme and the World Organisation for Animal Health, for strengthening collaboration to address resistance across human, animal and environmental health.
He, however, urged governments to move beyond developing policies to implementing funded national action plans with clear responsibilities and measurable results, stressing the need for domestic investment in laboratories, surveillance systems and responsible antimicrobial use.
He also called on health professionals, veterinary practitioners and agricultural workers to prevent infections and use antimicrobials responsibly, while urging researchers, industries and development partners to expand access to diagnostics and treatments and strengthen evidence for policy decisions.
He said WHO would continue working with countries and partners to strengthen the One Health response and protect the effectiveness of medicines essential to modern healthcare.
“AMR is everyone’s business. Let us each choose one concrete action this week, sustain it throughout the year, and encourage others to act,” he said.
He warned that without sustained collective action, medicines that have saved millions of lives could become increasingly ineffective, threatening the ability of health systems to treat infections and deliver critical medical interventions.


